Obesity Featured Articles

  1. Slot Allocation Is A Problem For Patients And PIs In Phase 1 Oncology Trials (Part 1) 4/10/2026

    Given the shift in the size and scope of oncology Phase 1 trials, cohort management and slot allocation strategies must change, too. Nehal Lakhani, MD, Ph.D. explains why competitive slot allocation is no longer optimal for patients or PIs.

  2. There's A Gap In Brain Tumor Research — Here's How We Fix It 4/9/2026

    Brain tumors are some of the most biologically complex and least improved indications. Biochemistry researcher and scientist Catherine Bladen, Ph.D., argues sustained focus is a key to driving real-world progress.

  3. Lessons Learned While Taking Glioblastoma Drug From Bench To Clinic 4/9/2026

    MimiVax CEO Mike Ciesielski recounts the company's transition from academia to industry, hitting on topics like vendor partnerships, FDA conversations, and manufacturer selection. 

  4. How Australia's Leading CRO Is Driving Biotech's Acceleration From First-In-Human To Global Markets 4/8/2026

    The next era of clinical trials will be defined by global expansion across the Asia-Pacific region, rapid and cost-effective pathways to regulatory approval, and reliable, patient-centric leadership.

  5. The Much-Feared FDA Form 483, Part 3 4/8/2026

    This final installment in this three-part series offers an example of how the misperception of the 483 as a surrogate for overall quality of a firm can lead to policy errors in attempting to mitigate pricing problems with generic drugs.

  6. Considerations For Allergic Rhinitis Trials Are Nothing To Sneeze At 4/8/2026

    Inimmune CEO David Burkhart explains how a GSK layoff led to the formation of a new company focused on treating allergic rhinitis. Here, he shares success from the company's approach to site selection, trial design, and timing.

  7. Rare Diseases And The Integrated CDMO Support System 4/7/2026

    Champion the rare‑disease community by advancing development models built on precision, continuity and global coordination that ensure every dose reaches the patients who need it most.

  8. Clinical, Commercial Packaging: Delivering Next-Gen Therapies 4/7/2026

    See how strategic, agile, and sustainable packaging is transforming drug delivery into a key driver of speed, safety, and patient-centric innovation.

  9. UK Regulatory Reforms 4/7/2026

    Stay ahead of the evolving UK regulatory landscape and leverage upcoming reforms to accelerate patient access, drive innovation, and strengthen your position in the medicines development market.

  10. Redefining Patient Outcomes Measurement Using RWE Data 4/7/2026

    Discover an outcome-channeling framework that organizes patient outcomes into multidimensional domains, emphasing longitudinal trajectories rather than single time endpoints.